image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Immunodiagnositcs

August 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • IDH
  • Price:
  • 720p
The shares have had a good month hitting a new high after news that the iSYS instrument and automated Vitamin D immunoassay kit had got FDA approval at long last. This will enable the system (device and test) to be launched in the US immediately. As we said in January, the US is IDS' biggest market and it has already had notable success there with its “manual” Vitamin D testing products - with sales of this test increasing by 72% from £12m to £22m in the year to 31 March. Vitamin D testing remains at an elevated state worldwide and has clearly been the main driver to sales growth, which overall ballooned by 49% to £37.1m.  Pretax profit was up 130% to £11m and eps were up 78% to 28.9p. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Immunodiagnositcs (November 2010)
Immunodiagnostics - Shares rocket as vitamins D testing lifts off (January 2010)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW